Search result for GW Pharma
CBD-oriented epilepsy launched by the GW Pharma
GW Pharma has been cleared to market the first plant-derived cannabis-based medicine in Europe to treat epilepsy conditions, CEO Justin Gover told CNBC’s Jim Cramer Tuesday. European Union officials this week approved the use of Epidyolex to treat seizures in patients with two rare, severe forms ...